Athersys to Present at Biotech Showcase(TM) 2013

Athersys to Present at Biotech Showcase(TM) 2013

CLEVELAND, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX)
announced today that William (B.J.) Lehmann, President and Chief Operating
Officer, will present at the Biotech Showcase^TM 2013 Conference to be held
January 7 through January 9, 2013 in San Francisco, California.

Details of Athersys' participation are as follows:

Event:     Biotech Showcase™ 2013 Conference
Date:     Tuesday, January 8, 2013
Time:     3:15 p.m. Pacific Time
Location:  Room Powell: Parc 55 Wyndham San Francisco Union Square Hotel

Earlier that same morning, Dr. Gil Van Bokkelen, Chairman and Chief Executive
Officer of Athersys, will participate in a panel entitled "The 2013
Regenerative Medicine State of the Industry Briefing," from 8:00 to 10:00 a.m.
Pacific Time.

Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech
Showcase is an investor and partnering conference devoted to providing private
and public biotechnology and life sciences companies an opportunity to present
to, and meet with, investors and pharmaceutical executives during the course
of one of the industry's largest annual healthcare investor conferences. Now
in its fifth year, Biotech Showcase is expected to attract upwards of 1,500
attendees.

About Athersys

Athersys is a clinical stage biotechnology company engaged in the discovery
and development of therapeutic product candidates designed to extend and
enhance the quality of human life. The Company is developing its MultiStem^®
cell therapy product, a patented, adult-derived "off-the-shelf" stem cell
product platform for disease indications in the cardiovascular, neurological,
inflammatory and immune disease areas. The Company currently has several
clinical stage programs involving MultiStem, including for treating
inflammatory bowel disease, ischemic stroke, damage caused by myocardial
infarction, and for the prevention of graft-versus-host disease. Athersys has
also developed a diverse portfolio that includes other technologies and
product development opportunities, and has forged strategic partnerships and
collaborations with leading pharmaceutical and biotechnology companies, as
well as world-renowned research institutions in the United States and Europe
to further develop its platform and products. More information is available at
www.athersys.com.

The Athersys, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=4548

About Demy-Colton Life Science Advisors

Demy-Colton Life Science Advisors is focused exclusively on facilitating the
growth of the life science industry. Now going into its fifth year,
Demy-Colton has developed a number of high-value added conferences to address
the business and development needs of the biotechnology industry; it provides
partnering services and it has helped launch a unique investor website and
newsletter. For more information please visit www.demy-colton.com.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry.
Since 1993, biotech, pharma and medical device companies have leveraged EBD
Group's partnering conferences, technology and services to identify business
opportunities and develop strategic relationships essential to their success.
For more information please visit www.ebdgroup.com or follow EBD Group on
Twitter at twitter.com/ebdgroup.

CONTACT: William (B.J.) Lehmann, J.D.
         President and Chief Operating Officer
         Tel: (216) 431-9900
         bjlehmann@athersys.com
        
         Investor Relations:
         Lisa M. Wilson
         In-Site Communications
         Tel: (917) 543-9932
         lwilson@insitecony.com

company logo